MedPage Today - Latest Medical News/Health News Headlines

Latest Headlines News
  1. (MedPage Today) -- SAN FRANCISCO -- The investigational complement-targeting agent claseprubart was safe and led to significant improvements in generalized myasthenia gravis (MG), the phase II MaGic trial showed. The trial tested two doses of...
  2. (MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of Texas Tech Health El Paso, look at the top medical...
  3. (MedPage Today) -- When President Trump and Health Secretary Robert F. Kennedy Jr. asserted an unproven link between acetaminophen (Tylenol) and autism, it appeared to be just another salvo in the administration's ongoing perpetuation of scientific...
  4. (MedPage Today) -- Plan on a glorious extra hour of sleep as most of America "falls back" into standard time. But make sure to get outside for some morning sun, too -- it'll help your body clock reset faster. Daylight saving time ends at 2 a...
  5. (MedPage Today) -- Exposure to SARS-CoV-2 infection in utero was associated with an increased risk of neurodevelopmental diagnoses among children by age 3 years, according to a retrospective cohort study. Among over 800 children exposed to maternal...
  6. (MedPage Today) -- SAN ANTONIO -- Despite previous concerns, a single infusion of the nonsteroidal anti-inflammatory drug (NSAID) ketorolac alongside standard analgesics was a safe and efficacious pain control option after egg retrieval, a double...
  7. (MedPage Today) -- Two federal judges ruled nearly simultaneously on Friday that President Donald Trump's administration must continue to fund the Supplemental Nutrition Assistance Program (SNAP), the nation's biggest food aid program, using contingency...
  8. (MedPage Today) -- The ultimate irony: A lung cancer researcher was denied treatment for advanced lung cancer. (Stanford Daily) The diabetes and weight-loss drug tirzepatide (Mounjaro, Zepbound) has surpassed the cancer agent pembrolizumab (Keytruda...